Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUMMR-BRA: Influenza and MMR Vaccines for COVID-19 Prevention
NCT05401448Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of influenza vaccine and measles, mumps, and rubella vaccine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Cumulative incidence of SARS-CoV-2 infection at 3 months. Started Jun 2021; status: completed.
02
Drugs
influenza vaccinemeasles, mumps, and rubella vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05401448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401448.